Purple blotch disease caused by Alternaria porri is a major constraint in shallot production and can significantly reduce plant productivity. This study aimed to identify the secondary metabolites produced by Bacillus sp. D28 using gas chromatography–mass spectrometry (GC-MS) and evaluate their efficacy in suppressing purple blotch disease and promoting shallot growth. An in vivo experiment was conducted under greenhouse conditions using a Completely Randomized Design with five treatments, namely untreated control, secondary metabolite concentrations of 20%, 30%, and 40%, and mancozeb at 0.40%. Each treatment consisted of five replications with four plants per replication. The observed parameters included disease incubation period, disease intensity, plant height, number of leaves, and control efficacy. Secondary metabolite application delayed symptom development and reduced disease intensity. The 40% treatment reduced disease intensity to 20.00% compared with 65.00% in the control, resulting in 69.23% control efficacy. It also increased plant height by approximately 59.96% compared with the control at 35 days after planting. Based on the calculated efficacy ratio, the 40% treatment showed 100% relative efficacy equivalence to mancozeb. These results indicate the potential of Bacillus sp. D28 secondary metabolites as an environmentally friendly alternative for purple blotch disease management in shallot production. Contribution to Sustainable Development Goals (SDGs):SDG 2: Zero HungerSDG 12: Responsible Consumption and Production SDG 15: Life on Land
Copyrights © 2027